Pacific Biosciences Of California | PACB - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Agilent USD 7.12B 214M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Danaher USD 52.58B 368M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Illumina USD 2.68B 47M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Quidel USD 1.85B 69.1M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Roche Holding CHF 32.69B 1.11B 2026-06
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 2.56B 230.55M 2025-12